BioLive Wire · AI-collected
Moderna Will Reveal the Data for Its mRNA Cancer Vaccine Next Month
- Moderna will reveal the data for its mRNA cancer vaccine next month, according to MarketWatch.
Published Sep 21Source: MarketWatch ↗
NLP · 3-line summary
AI Articles & Report Summaries
Expert articles and reports as a 3-line summary + takeaway
BioLive Wire · AI-collected
Grail Rallies as FDA Staff Flags No Major Concerns for Multi-Cancer Test
- Grail shares rallied after FDA staff flagged no major concerns for its multi-cancer test, according to Investing.com.
Published Sep 21Source: Investing.com ↗
BioLive Wire · AI-collected
Weight-Loss Drug Developers Line Up to Tap Lucrative Market as Competition Heats Up
- Weight-loss drug developers are lining up to tap the lucrative market as competition heats up, according to a Reuters factbox relayed by Investing.com.
Published Sep 21Source: Investing.com ↗
BioLive Wire · AI-collected
Insmed Stock Rises on FDA Priority Review for Arikayce
- Insmed shares rose after the FDA granted priority review for Arikayce, according to Investing.com.
Published Sep 21Source: Investing.com ↗
BioLive Wire · AI-collected
Ipsen Shares Fall 7% After US Approval of Generic Somatuline Rival
- Ipsen shares fell 7% after the US approved a generic rival to its Somatuline drug, according to Investing.com.
Published Sep 21Source: Investing.com ↗
BioLive Wire · AI-collected
Syncona Jumps 6% After Beacon Gene Therapy Trial Success
- Syncona shares jumped 6% after Beacon's gene therapy trial success, according to Investing.com.
Published Sep 21Source: Investing.com ↗
BioLive Wire · AI-collected
Novo Nordisk Stock Tumbles as Ozempic Maker Sets Out 2030 Goals
- Novo Nordisk stock tumbled as the Ozempic maker set out its 2030 goals, according to MarketWatch.
Published Sep 21Source: MarketWatch ↗
BioLive Wire · AI-collected
Australia's Telix Agrees to Buy Germany's ITM Isotope for $1.65 Billion
- Australia's Telix Pharmaceuticals agreed to buy Germany's ITM Isotope for $1.65 billion, according to Investing.com.
Published Sep 20Source: Investing.com ↗
BioLive Wire · AI-collected
US Weighs Allowing Most Pharma Licensing Deals With China, Sources Say
- The US is weighing allowing most pharma licensing deals with China, according to an exclusive Reuters report via Investing.com.
Published Sep 18Source: Investing.com ↗
BioLive Wire · AI-collected
US Plans Medicaid Most-Favored-Nation Pricing for Some Drugs in All States, Semafor Reports
- The US plans to implement Medicaid most-favored-nation pricing for some drugs across all states, according to a Semafor report carried by Investing.com.
Published Sep 18Source: Investing.com ↗
BioLive Wire · AI-collected
Ultragenyx Sets $3.95 Million Price for Rare Disease Gene Therapy
- Ultragenyx set a $3.95 million price for its rare disease gene therapy, according to Reuters via Investing.com.
- This follows the FDA's approval of the gene therapy.
Published Sep 17Source: Investing.com ↗
BioLive Wire · AI-collected
Electra Therapeutics IPO Expected to Price Above Midpoint
- Electra Therapeutics' IPO is expected to price above the midpoint of its range, according to Investing.com.
- This follows the company's earlier filing for an IPO to fund immune disease drugs.
Published Sep 17Source: Investing.com ↗
BioLive Wire · AI-collected
Beta Bionics Stock Rises After FDA Clears Mint Patch Pump
- Beta Bionics shares rose after the FDA cleared its Mint patch pump, according to Investing.com.
Published Sep 14Source: Investing.com ↗
BioLive Wire · AI-collected
Bayer's Monsanto Unit Urges Missouri Judge to Approve $7.25 Billion Roundup Settlement
- Bayer's Monsanto unit urged a Missouri judge to approve its $7.25 billion Roundup settlement, according to Investing.com.
- This follows the earlier report that the settlement faced a pivotal court test in Missouri.
Published Sep 14Source: Investing.com ↗
BioLive Wire · AI-collected
Armata Pharmaceuticals Stock Rises on FDA Breakthrough Designation
- Armata Pharmaceuticals shares rose after the company received an FDA breakthrough therapy designation, according to Investing.com.
Published Sep 14Source: Investing.com ↗
BioLive Wire · AI-collected
Apollo Global in Talks to Acquire J&J's Orthopedics Unit, Bloomberg News Reports
- Apollo Global is in talks to acquire J&J's orthopedics unit, according to a Bloomberg News report cited by Investing.com.
Published Sep 11Source: Investing.com ↗
BioLive Wire · AI-collected
AstraZeneca Breast Cancer Drug Fails Late-Stage Trial Goal
- AstraZeneca's breast cancer drug failed its late-stage trial goal, according to an Investing.com report.
Published Sep 11Source: Investing.com ↗
BioLive Wire · AI-collected
GSK to Close German Vaccine Plant, 641 Jobs at Risk
- GSK will close a German vaccine plant, putting 641 jobs at risk, according to an Investing.com report.
Published Sep 11Source: Investing.com ↗
BioLive Wire · AI-collected
Bayer Faces Pivotal Test of $7.25 Billion Roundup Settlement in Missouri Court
- Bayer faces a pivotal test of its $7.25 billion Roundup settlement in a Missouri court, according to an Investing.com report.
- This follows an earlier report that Bayer and plaintiffs sought a delay in a Roundup settlement hearing.
Published Sep 11Source: Investing.com ↗
BioLive Wire · AI-collected
Novartis Investors Turn Spotlight on M&A After Trial Setbacks
- Novartis investors turned their spotlight on M&A after recent trial setbacks, according to an Investing.com report.
- This follows earlier reports of a failed cholesterol drug trial and a major shareholder's call for a board shake-up.
Published Sep 11Source: Investing.com ↗
BioLive Wire · AI-collected
Major Novartis Shareholder Calls for Board Shake-Up After Drug Trial Setbacks
- A major Novartis shareholder called for a board shake-up after recent drug trial setbacks, according to an exclusive Investing.com report.
- This follows Novartis's earlier-reported failed cholesterol drug trial and subsequent biopharma stock selloff.
Published Sep 10Source: Investing.com ↗
BioLive Wire · AI-collected
IQVIA Stock Rises Amid $2 Billion Senior Notes Offering
- IQVIA stock rose amid a $2 billion senior notes offering, according to an Investing.com report.
Published Sep 9Source: Investing.com ↗
BioLive Wire · AI-collected
Amgen and AstraZeneca Report Positive Lung Cancer Trial Results
- Amgen and AstraZeneca reported positive lung cancer trial results, according to an Investing.com report.
Published Sep 9Source: Investing.com ↗
BioLive Wire · AI-collected
Roivant Shares Jump 17% as Lung Disease Drug Meets Trial Goals
- Roivant shares jumped 17% as its lung disease drug met trial goals, according to an Investing.com report.
Published Sep 8Source: Investing.com ↗